Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference77 articles.
1. Glioblastoma survival in the United States before and during the temozolomide era;Johnson;J Neurooncol,2012
2. Next-generation sequencing applied to molecular diagnostics;Natrajan;Expert Rev Mol Diagn,2011
3. Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments;Galanis;Curr Oncol Rep,2011
4. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations;von Deimling;Brain Pathol,2011
5. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol;PLOS ONE;2024-07-26
2. Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells;Science Advances;2024-06-07
3. Enhanced Glioma Disease Prediction Through Ensemble-Optimized Machine Learning;2024 International Conference on Communication, Computer Sciences and Engineering (IC3SE);2024-05-09
4. Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells;2024-02-07
5. Anticancer Effects of Alpha-lipoic Acid on A172 and U373 Human Glioblastoma Cells;Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi;2023-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3